3 months | 12 months | |
---|---|---|
Primary outcomes | ||
Difference between BI and BAU in: | ||
a) number of headache days per month | X | |
b) number of headache medication days per month | X | |
Change relative to baseline in | ||
a) number of headache days per month | X | |
b) number of headache medication days per month | X | |
Secondary outcomes | ||
Difference between BI and BAU in proportion of cases without chronic headache and without medication overuse | X | |
Change relative to baseline in proportion of patients with more than | ||
a) 25% reduction of headache days | X | X |
b) 50% reduction of headache days | X | X |
Change relative to baseline in headache index (Area under curve for headache intensity versus time) | X | X |
Change relative to baseline in | ||
a) headache days from headache diary | X | X |
b) medication days from diary | X | X |
Change relative to baseline in average headache intensity recorded by VAS (from headache diary) | X | X |
Change relative to 3 month follow-up in self-reported health related costs | X | |
Change relative to 3 month follow-up in quality of life recorded as SF-36 and MIDAS/HIT-6 | X | |
Change relative to baseline in: | ||
a) number of headache days per month | X | |
b) number of headache medication days per month | X | |
Relapse rate compared with status at 3 month | X |